AstraZeneca PLC
AstraZeneca PLC discovers, develops, and commercializes prescription medicines in the areas of oncology, cardiovascular, renal and metabolism, respiratory, autoimmunity, infection, neuroscience, and gastroenterology worldwide. Its marketed products include Arimidex, Casodex/Cosudex, Calquence, Faslodex, Imfinzi, Iressa, Lynparza, Nolvadex, Tagrisso, and Zoladex for oncology diseases; Atacand/Atacand HCT/Atacand Plus, Brilinta/Brilique, Crestor, Plendil, Seloken/Toprol-XL, Tenormin, and Zestril for cardiovascular diseases; and Bydureon, Byetta, Farxiga/Forxiga, Kombiglyze XR/Komboglyze, Onglyza, Qtern, Symlin, Xigduo/Xigduo XR for metabolic diseases. The company's marketed products also comprise Accolate, Bevespi Aerosphere, Bricanyl Respules, Bricanyl Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Tudorza/Eklira, Fasenra, Oxis Turbuhaler, Pulmicort Turbuhaler/Pulmicort Flexhaler, Pulmicort Respules, Symbicort pMDI, and Symbicort Turbuhaler for respiratory diseases; Fluenz Tetra/FluMist Quadrivalen and Synagis for infection diseases; Movantik/Moventig, Seroquel IR/Seroquel XR, and Vimovo for neuroscience diseases; and Losec/Prilosec and Nexium for gastrointestinal diseases. The company serves primary care and specialty care physicians through distributors and local representative offices. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was founded in 1992 and is headquartered in Cambridge, the United Kingdom. Show More...
-
Website http://www.astrazeneca.com
-
Sector Healthcare
-
Industry Drug Manufacturers-General
-
Last Quote 72.83 USD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD 2.79 3.63 2.47 1.02 0.49 1.11 1.38 1.19 0.85 0.52 0.57 Dividends USD 1.21 1.35 1.43 1.4 1.4 1.4 1.4 1.4 1.4 1.4 1.4 Payout Ratio % * 43.3 37.1 57.2 75.4 345.7 209.0 144.3 100.3 146.6 173.9 243.5 Shares Mil 2.892 2.734 2.528 2.508 2.528 2.53 2.532 2.534 2.534 2.602 2.625 Book Value Per Share * USD 8.24 9.26 9.52 9.25 8.09 6.86 5.17 5.42 4.71 4.64 4.11 Free Cash Flow Per Share * USD 2.94 2.48 0.92 2.37 1.83 0.74 0.22 1.12 -0.05 0.52 Return on Assets % 14.5 18.32 11.84 4.67 2.15 4.76 5.71 4.77 3.48 2.19 2.57 Financial Leverage (Average) 2.42 2.27 2.26 2.41 2.99 3.25 4.21 4.23 4.86 4.68 5.31 Return on Equity % 36.71 42.98 26.81 10.89 5.75 14.82 20.99 20.13 15.71 10.43 14.32 Return on Invested Capital % 30.49 31.78 21.2 8.7 5.32 10.07 12.61 11.04 8.37 5.97 6.71 Interest Coverage 11.74 13.62 9.27 7.64 3.44 7.54 6.22 4.12 3.5 2.86 3.16 Current Ratio 1.5 1.49 1.37 1.27 0.96 1.08 0.87 0.8 0.95 0.85 0.75 Quick Ratio 1.16 1.31 1.08 1.02 0.75 0.81 0.68 0.57 0.68 0.61 0.54 Debt/Equity 0.39 0.32 0.4 0.37 0.43 0.76 0.98 1.04 1.39 1.24 1.49